These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2456788)
1. Differential actions of phosphodiesterase inhibitors on secretin- and vasoactive intestinal peptide-induced increases in chief cell cAMP. Raufman JP; Cosowsky L Biochim Biophys Acta; 1988 Jul; 970(3):318-23. PubMed ID: 2456788 [TBL] [Abstract][Full Text] [Related]
2. Effects of inhibitors of cyclic nucleotide phosphodiesterase on the actions of vasoactive intestinal peptide and secretin on pancreatic acini. Gardner JD; Korman LY; Walker MD; Sutliff VE Am J Physiol; 1982 Jun; 242(6):G547-51. PubMed ID: 6178297 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of calcitonin gene-related peptide in stimulating pancreatic enzyme secretion. Zhou ZC; Villanueva ML; Noguchi M; Jones SW; Gardner JD; Jensen RT Am J Physiol; 1986 Sep; 251(3 Pt 1):G391-7. PubMed ID: 2428255 [TBL] [Abstract][Full Text] [Related]
4. Actions of vasoactive intestinal peptide and secretin on chief cells prepared from guinea pig stomach. Sutliff VE; Raufman JP; Jensen RT; Gardner JD Am J Physiol; 1986 Jul; 251(1 Pt 1):G96-102. PubMed ID: 3014896 [TBL] [Abstract][Full Text] [Related]
5. Effects of inhibitors of cyclic nucleotide phosphodiesterase on actions of cholecystokinin, bombesin, and carbachol on pancreatic acini. Gardner JD; Sutliff VE; Walker MD; Jensen RT Am J Physiol; 1983 Nov; 245(5 Pt 1):G676-80. PubMed ID: 6195928 [TBL] [Abstract][Full Text] [Related]
6. Relation of prostaglandin-induced increases in cellular cAMP to stimulation of pepsinogen secretion from dispersed chief cells. Raufman JP; Cosowsky L J Cell Physiol; 1987 Jul; 132(1):137-42. PubMed ID: 2439520 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of pepsinogen secretion from dispersed glands from rat stomach. Raufman JP; Kasbekar DK; Jensen RT; Gardner JD Am J Physiol; 1983 Oct; 245(4):G525-30. PubMed ID: 6194695 [TBL] [Abstract][Full Text] [Related]
8. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes. Elks ML; Manganiello VC Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009 [TBL] [Abstract][Full Text] [Related]
9. Regulation of pepsinogen release from canine chief cells in primary monolayer culture. Sanders MJ; Amirian DA; Ayalon A; Soll AH Am J Physiol; 1983 Nov; 245(5 Pt 1):G641-6. PubMed ID: 6195927 [TBL] [Abstract][Full Text] [Related]
10. Actions of peptide YY and neuropeptide Y on chief cells from guinea pig stomach. Raufman JP; Singh L Am J Physiol; 1991 Jun; 260(6 Pt 1):G820-6. PubMed ID: 1647673 [TBL] [Abstract][Full Text] [Related]
11. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum. Gespach C; Hui Bon Hoa D; Rosselin G Endocrinology; 1983 May; 112(5):1597-606. PubMed ID: 6131813 [TBL] [Abstract][Full Text] [Related]
12. Secretin and vasoactive intestinal peptide are potent stimulants of cellular contraction and accumulation of cyclic AMP in rat ventricular cardiomyocytes. Bell D; McDermott BJ J Cardiovasc Pharmacol; 1994 Jun; 23(6):959-69. PubMed ID: 7523789 [TBL] [Abstract][Full Text] [Related]
13. Evidence for a cyclic AMP system highly sensitive to secretin in gastric glands isolated from the rat fundus and antrum. Gespach C; Bataille D; Dupont C; Rosselin G; Wünsch E; Jaeger E Biochim Biophys Acta; 1980 Jul; 630(3):433-41. PubMed ID: 6249385 [TBL] [Abstract][Full Text] [Related]
14. Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1. Emami S; Gespach C; Forgue-Lafitte ME; Broer Y; Rosselin G Life Sci; 1983 Aug; 33(5):415-23. PubMed ID: 6192308 [TBL] [Abstract][Full Text] [Related]
15. Effects of peptides of the secretin-glucagon family and cyclic nucleotides on tyrosine hydroxylase activity in sympathetic nerve endings. Schwarzschild MA; Zigmond RE J Neurochem; 1991 Feb; 56(2):400-6. PubMed ID: 1703218 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism. Shechter Y Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014 [TBL] [Abstract][Full Text] [Related]
17. Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitors. Wachtel H J Neural Transm; 1983; 56(2-3):139-52. PubMed ID: 6190991 [TBL] [Abstract][Full Text] [Related]
18. The lack of correlation between inhibition of aggregation and cAMP levels with canine platelets. Tsien WH; Sass SP; Sheppard H Thromb Res; 1982 Nov; 28(4):509-19. PubMed ID: 6187084 [TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterases in the rat renal vasculature. Jackson EK; Mi Z; Carcillo JA; Gillespie DG; Dubey RK J Cardiovasc Pharmacol; 1997 Dec; 30(6):798-801. PubMed ID: 9436820 [TBL] [Abstract][Full Text] [Related]